Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
Dianthus Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Dianthus Therapeutics reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at Dianthus Therapeutics received on average a compensation package of $3.4M, a 467% increase compared to previous year.
Average pay of disclosed executives at Dianthus Therapeutics
Jason Gardner, Chief Executive Officer, received $4.7M in total, which increased by 692% compared to 2017. 85% of Gardner's compensation, or $4M, was in option awards. Gardner also received $250K in non-equity incentive plan and $460K in salary.
John C. Davis, Jr., Chief Medical Officer, received a compensation package of $3.2M. 80% of the compensation package, or $2.6M, was in option awards.
Christina K. Isacson, Chief Business Officer, earned $2.3M in 2018.
Related executives
You may also like
Source: SEC filing on April 25, 2019.